Bottom line
FACDX vs HGHAX: the short answer
FACDX (Fidelity Advisor Health Care Fund) and HGHAX (The Hartford Healthcare Fund) are both mutual funds.
FACDX is cheaper at 0.96% vs 1.33% — a difference of $37 a year per $10,000 invested.
HGHAX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
FACDX vs HGHAX side by side
| FACDX | HGHAX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Fidelity | Hartford |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.96% | 1.33% |
| Annual cost per $10k | $96 | $133 |
| 10-yr cost on $10k (prospectus) | $1,685 | $2,063 |
| Max front load | — | 5.5% |
| 12b-1 fee | 0.25% | 0.25% |
| 1-yr return | +7.7% | — |
| 5-yr return (annualized) | +2.3% | — |
| 10-yr return (annualized) | +7.6% | — |
| Best quarter | +21.3% | +20.9% |
| Worst quarter | −15.0% | −15.7% |
| Net assets (fund) | $3.1B | $772.2M |
| Number of holdings | 154 | 80 |
| Portfolio turnover | 74% | 49% |
| Returns as of | Sep 30, 2026 | — |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FACDX | HGHAX | Difference |
|---|---|---|---|
| 2025 | +14.2% | +15.6% | −1.4% |
| 2024 | +3.9% | 0.0% | +3.9% |
| 2023 | +3.8% | +3.8% | +0.0% |
| 2022 | −13.1% | −11.7% | −1.3% |
| 2021 | +11.2% | +10.0% | +1.2% |
| 2020 | +21.1% | +22.6% | −1.5% |
| 2019 | +27.9% | +33.3% | −5.4% |
| 2018 | +7.3% | −3.0% | +10.3% |
| 2017 | +24.1% | +21.6% | +2.5% |
| 2016 | −10.3% | −8.6% | −1.8% |
Source: Fund prospectus bar charts
Holdings overlap
10 of FACDX's top 25 holdings also appear in HGHAX's top 25.
| Holding | FACDX | HGHAX |
|---|---|---|
| ELI LILLY and CO | 7.66% | 12.03% |
| Danaher Corp | 6.75% | 2.57% |
| Thermo Fisher Scientific Inc | 6.31% | 1.58% |
| Unitedhealth Group Inc | 4.17% | 4.74% |
| JOHNSON and JOHNSON | 3.78% | 6.75% |
| Abbvie Inc | 3.62% | 4.21% |
| MERCK and CO INC | 2.09% | 6.00% |
| Agilent Technologies Inc | 1.75% | 1.54% |
| Cvs Health Corp | 1.29% | 2.84% |
| Boston Scientific Corp | 1.23% | 1.88% |
Source: SEC Form N-PORT
FACDX top 10
- ELI LILLY and CO — 7.66%
- Danaher Corp — 6.75%
- Thermo Fisher Scientific Inc — 6.31%
- Unitedhealth Group Inc — 4.17%
- JOHNSON and JOHNSON — 3.78%
- Abbvie Inc — 3.62%
- Fidelity Revere Street Trust — 2.54%
- Argenx Se — 2.09%
- MERCK and CO INC — 2.09%
- West Pharmaceutical Svcs Inc — 2.06%
HGHAX top 10
- Eli Lilly & Co — 12.03%
- Johnson & Johnson — 6.75%
- Merck & Co Inc — 6.00%
- UnitedHealth Group Inc — 4.74%
- AbbVie Inc — 4.21%
- Elevance Health Inc — 3.00%
- Intuitive Surgical Inc — 2.88%
- CVS Health Corp — 2.84%
- Vertex Pharmaceuticals Inc — 2.64%
- Danaher Corp — 2.57%
FAQ
What is the difference between FACDX and HGHAX?
Which is cheaper, FACDX or HGHAX?
Should I own both FACDX and HGHAX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.